Page last updated: 2024-10-20

pyridoxine and Atherosclerotic Parkinsonism

pyridoxine has been researched along with Atherosclerotic Parkinsonism in 1 studies

4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol: structure in first source
vitamin B6 : Any member of the group of pyridines that exhibit biological activity against vitamin B6 deficiency. Vitamin B6 deficiency is associated with microcytic anemia, electroencephalographic abnormalities, dermatitis with cheilosis (scaling on the lips and cracks at the corners of the mouth) and glossitis (swollen tongue), depression and confusion, and weakened immune function. Vitamin B6 consists of the vitamers pyridoxine, pyridoxal, and pyridoxamine and their respective 5'-phosphate esters (and includes their corresponding ionized and salt forms).

Research Excerpts

ExcerptRelevanceReference
"Pyridoxine has been reported to attenuate the severity of levodopa-induced dyskinesias in patients with Parkinson's disease and it is suggested that pyridoxine supplementation should be considered in psychiatric patients with drug-induced movement disorders including persistent Parkinsonism."1.28Pyridoxine improves drug-induced parkinsonism and psychosis in a schizophrenic patient. ( Pardeshi, R; Sandyk, R, 1990)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sandyk, R1
Pardeshi, R1

Other Studies

1 other study available for pyridoxine and Atherosclerotic Parkinsonism

ArticleYear
Pyridoxine improves drug-induced parkinsonism and psychosis in a schizophrenic patient.
    The International journal of neuroscience, 1990, Volume: 52, Issue:3-4

    Topics: Adult; Dyskinesia, Drug-Induced; Humans; Male; Parkinson Disease, Secondary; Pyridoxine; Schizophren

1990